You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
沛嘉医疗-B(09996.HK)拟根据一般授权配售3380万股新股份
格隆汇 01-22 06:57

格隆汇 1 月 22日丨沛嘉医疗-B(09996.HK)发布公告,2021年1月22日(交易时间前),公司与配售代理(即摩根士丹利)订立配售协议,据此,公司已有条件同意透过配售代理,以每股配售股份29.38港元的价格,向不少于六名承配人配售合共3380万股配售股份。配售股份相当于本公告日期公司现有已发行股本约5.3%及紧随配售完成后公司经扩大已发行股本约5.1%。

配售股份将根据一般授权配发及发行,无需股东批准。假设3380万股配售股份获悉数认购,配售完成后,所得款项总额将为9.9304亿港元,配售所得款项净额估计为9.7148亿港元。配售须待(其中包括)联交所上市委员会批准配售股份上市及买卖(且上述上市及批准买卖随后并未于配售完成前被撤回),方可作实。公司将向联交所申请批准配售股份上市及买卖。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account